65626-22-4

Usage

Uses

Used in Food and Beverage Industry:
4-Methyltetrahydro-2H-pyran-4-carbaldehyde is used as a flavoring agent for its ability to impart a pleasant, fruity scent to food and beverages, enhancing the overall sensory experience for consumers.
Used in Perfumes and Cosmetics:
In the fragrance industry, 4-Methyltetrahydro-2H-pyran-4-carbaldehyde serves as an ingredient in perfumes and cosmetics, providing a sweet and floral aroma that contributes to the creation of desirable scents for personal care products.
Used in Medicinal Applications:
4-Methyltetrahydro-2H-pyran-4-carbaldehyde has been studied for its potential medicinal properties, such as anti-inflammatory and antioxidant effects. Its use in this field is aimed at developing treatments that can benefit from these characteristics, although further research is needed to fully understand its therapeutic potential.
Overall, 4-Methyltetrahydro-2H-pyran-4-carbaldehyde is a versatile compound with applications in the food and beverage, fragrance, and potentially medicinal industries, leveraging its unique sensory properties and potential health benefits.

Upstream product

• 502609-47-4 (4-methyltetrahydro-2H-pyran-4-yl)methanol 
• 110238-91-0 tetrahydropyran-4-carboxylic acid methyl ester 
• 443912-70-7 methyl 4-methyltetrahydro-2H-pyran-4-carboxylate 
• 96835-17-5 ethyl tetrahydro-2H-pyran-4-carboxylate 
• 861161-92-4 ethyl 4-methyltetrahydro-2H-pyran-4-carboxylate 
• 50675-18-8 3,4,5,6-tetrahydro-2H-pyran-4-carbaldehyde 
• 74-88-4 methyl iodide 

Downstream Products

• 1307304-95-5 C₁₆H₂₂N₂O₂ 
• 1307304-94-4 C₁₆H₂₂N₂O₂ 

Relevant academic research and scientific papers

Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)

Lp-PLA2 has been explored as a target for a number of inflammation associated diseases, including cardiovascular disease and dementia. This article describes the discovery of a new fragment derived chemotype that interacts with the active site of Lp-PLA2. The starting fragment hit was discovered through an X-ray fragment screen and showed no activity in the bioassay (IC50 > 1 mM). The fragment hit was optimized using a variety of structure-based drug design techniques, including virtual screening, fragment merging, and improvement of shape complementarity. A novel series of Lp-PLA2 inhibitors was generated with low lipophilicity and a promising pharmacokinetic profile.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia

Thermosensitive transient receptor potential melastatin 8 (TRPM8) antagonists are considered to be potential therapeutic agents for the treatment of cold hypersensitivity. The discovery of a new class of TRPM8 antagonists that shows in vivo efficacy in the rat chronic constriction injury (CCI)-induced model of neuropathic pain is described.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment o

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

A compound represented by formula (I) having mTOR inhibitory activity or a pharmacologically acceptable salt thereof.

2-Aminopyrimidine modulators of the histamine H4 receptor

2-Aminopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 /su

NOVEL PIPERIDINE/8-AZABICYCLO [3.2.1] OCTAN DERIVATIVES AS MODUILATORS OF CHEMOKINE RECEPTOR CCR5

Compounds of formula (I) wherein neither R4 nor R5 is hydrogen; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).

CHEMICAL COMPOUNDS

Compounds of formula (I): [Chemical formula should be inserted here. Please see paper copy] compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).

REVERSE HYDROXAMIC ACID DERIVATIVES

Reverse hydroxamic acid derivatives having specific structure represented by a general formula (Ia): (wherein A is a hydrogen atom or the like; Ar1 is an arylene or the like; Ar2 is an optionally substituted aryl, a heteroaryl or the